Canada Companion Animal Healthcare Market, by Diagnostics, 2018-2027

Growth Outlook

• The 2027 portion of the Canada Companion Animal Healthcare Market, by Diagnostics, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 122 Mn in 2026 and is projected to reach USD 132 Mn by 2027 — a gain of about 8% over the forecast period, translating to a CAGR in the high single digits.
• 2027: Others accounts for 30% of the combined USD total across these 4 groups, the largest single share.
• What the regional split looks like (2026): Others leads, holding roughly 30% of segment value — the single largest regional share. Diagnostic Imaging is the second-largest contributor. Immunodiagnostic Tests and Molecular Diagnostics make up the remainder, in descending order.
• By 2027, Others alone is expected to reach USD 40 Mn, with Diagnostic Imaging at USD 38 Mn.

Market Dynamics

2027: Others accounts for 30% of the combined USD total across these 4 groups, the largest single share.

Second place: Diagnostic Imaging, 37.83M USD, trailing Others by 6%.

Others: 20.84M USD to 40.16M USD, 93% higher by 2027.

Diagnostic Imaging climbs from 20.72M USD (2018) to 37.83M USD (2027), a 83% gain.

Immunodiagnostic Tests: 16.17M USD in 2018 to 34.08M USD by 2027, up 111%.

Molecular Diagnostics: up 86% over the period, 10.69M USD to 19.86M USD.

The fastest mover is Immunodiagnostic Tests, up 111% over the period — a steeper climb than any of the other 4 groups here.

The 4-group total: 68.42M USD in 2018, 131.93M USD by 2027, 93% overall.

How The 4 Series Compare

With 4 series on one chart, the shape that matters is how the ranking shifts over time, not just where each line starts or ends.

Size and growth rate are two different questions here — a series can be small in absolute terms and still be growing the fastest of the group. Check both before drawing a conclusion.

Use this chart to size the Canada Companion Animal Healthcare market and to compare how fast it is expected to grow against adjacent markets — it works best as an input to a market-entry or investment decision, not as a standalone verdict.

Figures before the 2018 base year are historical estimates; the years through 2027 are projections built from industry data, company revenues, and primary interviews. Forecasts are revised as new data comes in, so check the full report for the latest assumptions.